Viewing Study NCT00946335


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-01-01 @ 3:16 AM
Study NCT ID: NCT00946335
Status: COMPLETED
Last Update Posted: 2014-07-09
First Post: 2009-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module